August 5th, 2026
Chemist’s fix for a stubborn biomanufacturing problem? Engineer the liquid, not the machine
Scaling biomanufacturing is often constrained by how efficiently gases move through liquids—FluxBio, a Harvard startup out of the lab of Jarad Mason in the Department of Chemistry & Chemical Biology at Harvard, found a solution by re-engineering the liquid, not the machine. The microporous water technology received critical early support from the Blavatnik Biomedical Accelerator to advance while in the lab and ultimately form the basis for FluxBio.
